TOKYO (Reuters) - U.S. Affymax Inc. and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys (peginesatide) in the U.S., due to reports of serious…
TOKYO, Feb 24 (Reuters) - U.S. Affymax Inc. and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anaemia treatment Omontys (peginesatide) in the U.S., due to reports of…
TOKYO Reuters U.S. Affymax Inc. and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys peginesatide in the U.S. due to reports of serious hypers…
(Reuters) - Affymax Inc said its partner Takeda Pharmaceutical Co Ltd entered into an agreement to supply their anemia drug to U.S. dialysis centers operated by Fresenius Medical Care.
